Table 2. VISORB study outcomes [25].
Clinical Response (PE measurement) | # of subjects (%) 34 (100) |
---|---|
Complete Response | 19 (56) |
Partial Response | 10 (29) |
Stable Disease | 2 (6) |
Progressive Disease | 0 (0) |
Not Evaluable | 3 (9) |
Histological Response | 27 (100) |
No sign of disease | 18 (67) |
Disease present (clear margins) | 6 (22) |
Disease present (extending to margins) | 3 (11) |